Home › Funds › GUGGENHEIM CAPITAL LLC › JNJ
GUGGENHEIM CAPITAL LLC position in JNJ
JOHNSON JOHNSON · Health Care
GUGGENHEIM CAPITAL LLC reported holding 274,166 shares of JNJ (JOHNSON JOHNSON) in its Q2 2026 13F filing — a position valued at US$69.6M, representing 0.45% of its reported portfolio and ranking #36 among its reported holdings. GUGGENHEIM CAPITAL LLC has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How GUGGENHEIM CAPITAL LLC's JNJ position evolved
GUGGENHEIM CAPITAL LLC first disclosed a stake in JNJ in Q3 2023 at 251,719 shares (US$39.2M). The position peaked in Q1 2026 at 299,878 shares, worth US$73.3M. Across 12 filings, GUGGENHEIM CAPITAL LLC increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 274,166 shares valued at US$69.6M — a reduction of -25,712 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 251.72K | $39.21M | New |
| Q4 2023 | 259.62K | $40.69M | Add |
| Q1 2024 | 286.67K | $45.35M | Add |
| Q2 2024 | 285.27K | $41.70M | Hold |
| Q3 2024 | 309.86K | $50.22M | Add |
| Q4 2024 | 280.52K | $40.57M | Reduce |
| Q1 2025 | 303.48K | $50.33M | Add |
| Q2 2025 | 334.60K | $51.11M | Add |
| Q3 2025 | 338.07K | $62.69M | Add |
| Q4 2025 | 329.77K | $68.25M | Reduce |
| Q1 2026 | 299.88K | $73.30M | Reduce |
| Q2 2026 | 274.17K | $69.63M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About JNJ and 13F data
JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JNJ
- BlackRock Inc 212.10M sh · $53.87B · Q2 2026
- Vanguard Group 240.35M sh · $49.74B · Q4 2025
- VANGUARD CAPITAL MANAGEMENT LLC 157.23M sh · $39.93B · Q2 2026
- STATE STREET CORP 133.48M sh · $32.63B · Q1 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 64.37M sh · $16.35B · Q2 2026
- GEODE CAPITAL MANAGEMENT, LLC 59.09M sh · $14.97B · Q2 2026
- Geode Capital Management 59.09M sh · $14.97B · Q2 2026
- Morgan Stanley 44.81M sh · $11.38B · Q2 2026
- Norges Bank Investment Management 31.83M sh · $8.08B · Q2 2026
- STATE FARM MUTUAL AUTOMOBILE INSURANCE CO 31.59M sh · $8.02B · Q2 2026
- Northern Trust Corp 28.79M sh · $7.31B · Q2 2026
- Bank of America Corp 23.44M sh · $5.95B · Q2 2026
More on GUGGENHEIM CAPITAL LLC
FAQ
How long has GUGGENHEIM CAPITAL LLC held JNJ?
GUGGENHEIM CAPITAL LLC has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is GUGGENHEIM CAPITAL LLC's current position in JNJ?
As of Q2 2026, GUGGENHEIM CAPITAL LLC holds 274.17K shares of JNJ (JOHNSON JOHNSON), valued at $69.63M, representing 0.45% of its reported portfolio and ranking #36.
Has GUGGENHEIM CAPITAL LLC been buying or selling JNJ?
In the latest 13F filing (Q2 2026), GUGGENHEIM CAPITAL LLC reduced its position in JNJ. The position peaked in Q1 2026 at 299.88K shares.
Which other funds hold JNJ?
Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.